This article is more than 5 years old. Information may no longer be current.

Ceterix Orthopaedics receives FDA 510(k) clearance for suture cartridge for meniscal repair

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Ceterix Orthopaedics Inc. announced it received FDA 510(k) clearance for the size 0 suture cartridge, an added feature for the NovoStitch Pro Meniscal Repair System, which will offer surgeons more options for repair of meniscal tears.

According to a company press release, the NovoStitch Pro allows surgeons to place stitches arthroscopically in tight joint compartments. With the new 0 suture cartridge, the system offers surgeons more options in suture sizes and reportedly allows them to pass a complete stitch within the knee joint without removing the device to reload the suture.

“Ceterix continues to bring advanced technology to orthopedic surgeons who are looking for better ways to preserve the meniscus,” John McCutcheon, Ceterix’s president and CEO, said in the release. “This latest innovation will be especially beneficial to those surgeons who prefer an ‘all-inside, all-suture’ procedure with a stronger suture for the more-demanding meniscal root repairs.”

Reference:

www.ceterix.com